RESUMO
To assess the epidemiology and burden of haemodialysis in Jordan, all patients on haemodialysis (1711 patients) were surveyed during September/October 2003. Mean age was 48.9 years, 56% were male, 86.8% were unemployed and 92% were poor. Mean distance to the haemodialysis service was 13.6 km. Annual hepatitis B and C seroconversion for patients negative before dialysis was 0.34% and 2.6% respectively. Prevalence of haemodialysis was 312 per million population; the incidence in 2002 was 111 per million population. Fatality rate at 1 year was 20%. Diabetes mellitus was the leading cause of haemodialysis, 29.2% of cases. Total estimated cost of haemodialysis in 2003 was US$ 29.7 million.
Assuntos
Efeitos Psicossociais da Doença , Falência Renal Crônica/epidemiologia , Falência Renal Crônica/terapia , Diálise Renal/economia , Adolescente , Adulto , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Causalidade , Criança , Pré-Escolar , Complicações do Diabetes/complicações , Feminino , Hepatite/economia , Hepatite/epidemiologia , Hepatite/etiologia , Hepatite B/economia , Hepatite B/epidemiologia , Hepatite B/etiologia , Humanos , Incidência , Jordânia/epidemiologia , Falência Renal Crônica/economia , Falência Renal Crônica/etiologia , Masculino , Pessoa de Meia-Idade , Vigilância da População , Prevalência , Diálise Renal/efeitos adversos , Fatores SocioeconômicosRESUMO
To assess the epidemiology and burden of haemodialysis in Jordan, all patients on haemodialysis [1711 patients] were surveyed during September/October 2003. Mean age was 48.9 years, 56% were male, 86.8% were unemployed and 92% were poor. Mean distance to the haemodialysis service was 13.6 km. Annual hepatitis B and C seroconversion for patients negative before dialysis was 0.34% and 2.6% respectively. Prevalence of haemodialysis was 312 per million population; the incidence in 2002 was 111 per million population. Fatality rate at 1 year was 20%. Diabetes mellitus was the leading cause of haemodialysis, 29.2% of cases. Total estimated cost of haemodialysis in 2003 was US$ 29.7 million
